Newsletter

Embers To Eden

Total Labels 1
Approved 1
Expired 0

Burnt Barn Distilling Co., Burnt Barn Distilling Co., LLC — Paradise, CA

California

About Embers To Eden

Embers To Eden is a vodka brand originating from California. The spirit is classified as an 80 to 89 proof vodka according to Alcohol and Tobacco Tax and Trade Bureau records. The brand holds one approved label registration in the TTB COLA database, with its label approval occurring in 2023. The brand currently maintains a single distinct product offering within the vodka category. As a California-based vodka producer, Embers To Eden represents the contemporary craft spirits landscape in the state, which has become an increasingly significant region for vodka production and innovation. The brand's entry into the market in recent years reflects the continued growth and diversification within the American vodka segment. With its 80 to 89 proof classification, the spirit falls within a standard strength range for vodka products, positioning it within conventional parameters for the category. The single product group designation indicates a focused approach to the brand's market offering, concentrating on a streamlined portfolio rather than extensive product line extensions.

Filter by:
Displaying 1 results
Label Name Spirit Type Status Approval Date Producer
Vodka 80-89 Proof
Embers To Eden

VODKA 80-89 PROOF

Vodka 80-89 Proof Approved 2023-04-13 Burnt Barn Distilling Co., Burnt Barn Distilling Co., LLC

Page 1 of 1

1

Embers To Eden at a Glance

Embers To Eden has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2023-04-13 and 2023-04-13. Produced in California.

All information sourced from public TTB records.

Are you the owner or distributor of Embers To Eden?

Claim this brand listing to update information or get featured. Contact [email protected].

Produced At

Burnt Barn Distilling CO., Burnt Barn Distilling CO., LLC

Related Brands

Related Questions

Browse All Labels

Stay informed

Newsletter coming soon.

Follow us on X for new approvals, launches, and industry intelligence.